Cisplatin-Associated Acute Kidney Injury (CP-AKI) Risk Calculator
Predicts the risk of acute kidney injury in patients treated with intravenous cisplatin.
- Utilize the most recent lab values obtained prior to receiving cisplatin.
- This tool calculates the risk of CP-AKI, defined as a ≥2-fold rise in serum creatinine or the need for kidney replacement therapy within 14 days following cisplatin administration.
Advice
- As risk of cisplatin-associated AKI increases, consider closer monitoring.
- Use clinical judgement to determine if alternative therapies should be considered.